gemcitabine

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer
C. J. Poole, T. Perren, S. Gawande, M. Ridderheim, J. Cook, A. Jenkins, D. Roychowdhury

International Journal of Gynecologic Cancer Mar 2006, 16 (2) 507-514; DOI: 10.1136/ijgc-00009577-200603000-00008
Preclinical in vivo activity of a combination gemcitabine/liposomal doxorubicin against cisplatin‐resistant human ovarian cancer (A2780/CDDP)
D. Gallo, E. Fruscella, C. Ferlini, P. Apollonio, S. Mancuso, G. Scambia

International Journal of Gynecologic Cancer Jan 2006, 16 (1) 222-230; DOI: 10.1136/ijgc-00009577-200601000-00036
Gemcitabine–carboplatin–paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients
L. Fuso, F. Amant, P. Neven, P. Berteloot, I. Vergote

International Journal of Gynecologic Cancer Jan 2006, 16 (Suppl 1) 60-67; DOI: 10.1136/ijgc-00009577-200602001-00010
Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives
D. LORUSSO, G. FERRANDINA, E. FRUSCELLA, L. MARINI, V. ADAMO, G. SCAMBIA

International Journal of Gynecologic Cancer Nov 2005, 15 (6) 1002-1013; DOI: 10.1136/ijgc-00009577-200511000-00002
Gemcitabine reverses platinum resistance in platinum-resistant ovarian and peritoneal carcinoma
P. G. Rose

International Journal of Gynecologic Cancer Apr 2005, 15 (Suppl 1) 18-22; DOI: 10.1136/ijgc-00009577-200505001-00004
Review of gemcitabine-based combinations for platinum-resistant ovarian cancer
J. Sehouli

International Journal of Gynecologic Cancer Apr 2005, 15 (Suppl 1) 23-30; DOI: 10.1136/ijgc-00009577-200505001-00005
Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer
J. Pfisterer, I. Vergote, A. Du Bois, E. Eisenhauer

International Journal of Gynecologic Cancer Apr 2005, 15 (Suppl 1) 36-41; DOI: 10.1136/ijgc-00009577-200505001-00007
CHEMORADIATION WITH GEMCITABINE FOR CERVICAL CANCER IN PATIENTS WITH RENAL FAILURE
A. Duenas, L. Cetina, L. Rivera, M. Candelaria, J. De la Garza

International Journal of Gynecologic Cancer Sep 2004, 14 (Suppl 1) 105; DOI: 10.1136/ijgc-00009577-200409001-00371
Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study
T. Bauknecht, A. Hefti, G. Morack, C. Villena-Heinsen, D. Wallwiener, D. Elling, G. V. Minckwitz, K. Mansouri, J. Blatter, G. P. Breitbach

International Journal of Gynecologic Cancer Feb 2003, 13 (2) 130-137; DOI: 10.1136/ijgc-00009577-200303000-00005
Gemcitabine in the treatment of ovarian cancer
S. W. Hansen

International Journal of Gynecologic Cancer Jul 2001, 11 (Suppl 1) 39-41; DOI: 10.1136/ijgc-00009577-200107001-00009

Main menu

gemcitabine

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

gemcitabine

Pages